Innate Immune Responses in Virus Infection
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 3548
Special Issue Editor
Special Issue Information
Dear Colleagues,
The innate immune response to viral infection encompasses a wide range of mechanisms of body cells and tissues that limit the establishment of viral infection, viral replication, and spread. Innate immunity is also a major driver of the adaptive immune response. The innate immune system includes the antiviral response of infected cells, their recognition by effector cells, mechanisms to eliminate damaged cells, and the inflammatory response. Many viruses have evolved various mechanisms to evade the host's innate immune response, including interference with metabolic pathways, inflammasomes, autophagy, and apoptosis. These strategies are a critical basis for their virulence and cell tropism. The innate immune response to viruses, therefore, involves not only the study of classical effector mechanisms, such as natural killer cells or type I interferon-induced antiviral states, but also a broad spectrum of cell and tissue functions. The tremendous progress in understanding the physiology of cellular processes makes it necessary to also look at them from the perspective of innate immunity to viruses and to continuously upgrade innate immune functions. This Special Issue focuses on compiling a wide range of research and review articles that can reveal new aspects and advances in understanding the mechanisms of innate immune responses to various viruses. The articles that potentially define novel targets for antiviral therapies are especially welcomed.
Prof. Dr. Pero Lučin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.